Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Nadeem Lone

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Medchemcomm|August 16, 2018
Imidazoles as potential anticancer agentsImran Ali, Mohammad Nadeem Lone, Haasan Y Aboul-Enein
Current Medicinal Chemistry|April 7, 2016
Advances in Nanocarriers for Anticancer Drugs DeliveryImran Ali, Mohammad Nadeem Lone, Mohammad Suhail, et al.
Current Drug Targets|March 10, 2015
Heterocyclic Scaffolds: Centrality in Anticancer Drug DevelopmentImran Ali, Mohammad Nadeem Lone, Zeid A Al-Othman, et al.
Applied Biochemistry and Biotechnology|February 28, 2023
Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase InhibitorsMohammad Nadeem Lone, Shazia Gul, Umar Mehraj, et al.
Seminars in Cancer Biology|March 12, 2022
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implicationsUmar Mehraj, Umar Mushtaq, Manzoor A Mir, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 18, 2025
Pesticide-induced epigenetic suppression of WNT signaling and NF-κB-driven inflammation impairs ovarian function in ratsJasmeena Jan, Wajid Mohammad Sheikh, Shazia Gul, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Medchemcomm|August 16, 2018
Imidazoles as potential anticancer agentsImran Ali, Mohammad Nadeem Lone, Haasan Y Aboul-Enein
Current Medicinal Chemistry|April 7, 2016
Advances in Nanocarriers for Anticancer Drugs DeliveryImran Ali, Mohammad Nadeem Lone, Mohammad Suhail, et al.
Current Drug Targets|March 10, 2015
Heterocyclic Scaffolds: Centrality in Anticancer Drug DevelopmentImran Ali, Mohammad Nadeem Lone, Zeid A Al-Othman, et al.
Applied Biochemistry and Biotechnology|February 28, 2023
Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase InhibitorsMohammad Nadeem Lone, Shazia Gul, Umar Mehraj, et al.
Seminars in Cancer Biology|March 12, 2022
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implicationsUmar Mehraj, Umar Mushtaq, Manzoor A Mir, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 18, 2025
Pesticide-induced epigenetic suppression of WNT signaling and NF-κB-driven inflammation impairs ovarian function in ratsJasmeena Jan, Wajid Mohammad Sheikh, Shazia Gul, et al.
Pageof 1